Systemic lupus erythematosus: review of synthetic drugs. - Wikidata - wikimedia - TriplyDB

Systemic lupus erythematosus: review of synthetic drugs.

Systemic lupus erythematosus: review of synthetic drugs.

http://www.wikidata.org/entity/Q34498515

about

Individualized patient decision-aid for immunosuppressive drugs in women with lupus nephritis: study protocol of a randomized, controlled trial Progressive Multifocal Leukoencephalopathy and Systemic Lupus Erythematosus: Focus on Etiology.The Impact of T Cell Vaccination in Alleviating and Regulating Systemic Lupus Erythematosus Manifestation The soluble cytoplasmic tail of CD45 (ct-CD45) in human plasma contributes to keep T cells in a quiescent state.Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies.Clinical relevance of P-glycoprotein activity on peripheral blood mononuclear cells and polymorphonuclear neutrophils to methotrexate in systemic lupus erythematosus patients.Analysis of clinical risk factors in relapsed patients with class IV lupus nephritis.

P2860

Q36265699-00A56F96-C20D-4FBB-85CB-48D63ADDBEE2 Q36766244-99177D61-BAC7-4FA1-B052-1E2FDAD80BA1 Q37511805-E56362BA-9976-4DBB-9A32-E44336E4CA9B Q37593731-9E49FF14-40A8-4A45-9EFF-62EF1EE9F72F Q38806513-CC6B8665-434C-44E4-8C5C-BA185F7F52D3 Q47822363-47923254-72B3-464B-8114-87F91D482148 Q55314394-51BF7A2C-EB7A-47FF-AD6E-4219A3714D40

P2860

Systemic lupus erythematosus: review of synthetic drugs.

http://www.wikidata.org/entity/Q34498515

description

2015 nî lūn-bûn

@nan

2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Systemic lupus erythematosus: review of synthetic drugs.

@ast

Systemic lupus erythematosus: review of synthetic drugs.

@en

Systemic lupus erythematosus: review of synthetic drugs.

@nl

type

label

Systemic lupus erythematosus: review of synthetic drugs.

@ast

Systemic lupus erythematosus: review of synthetic drugs.

@en

Systemic lupus erythematosus: review of synthetic drugs.

@nl

prefLabel

Systemic lupus erythematosus: review of synthetic drugs.

@ast

Systemic lupus erythematosus: review of synthetic drugs.

@en

Systemic lupus erythematosus: review of synthetic drugs.

@nl

P1433

Q34498515-58C7156A-D0CF-4041-A006-A8B96A6A80AE

P1476

Q34498515-35D4A7AB-50C0-4538-AF00-4CB02D830DA4

P2093

Q34498515-5BD97152-1B64-409E-86E1-6513E97D0CCC

Q34498515-69558615-7BF8-4907-99CB-A794D054852E

P2860

Q34498515-00B5AD17-C943-4C83-9136-76769C1FBD65

Q34498515-052AACC2-A5B7-4963-89F7-86695820B57F

Q34498515-0C2B4706-9D96-4861-A2A2-6F75B4BECD75

Q34498515-102525A2-C24F-45BF-85E9-D91059540111

Q34498515-10299566-0CCC-4C7C-A046-41FD5C1C2B3E

Q34498515-1108958A-44DC-4179-9BAA-902C407602A2

Q34498515-11443776-689B-451B-A914-483D49819D4C

Q34498515-13D37F01-EAF8-4AF5-88F6-D4F9DA4D1697

Q34498515-1B55EC3A-7143-4497-98E1-274144AB4FAB

Q34498515-1E4BC3EB-7F48-4A3B-9A1E-C4E15303CD00

P304

Q34498515-CFDE7F5C-9FED-47E3-BE87-B11F01BB0EA8

P31

Q34498515-30A530AF-9855-4450-84DA-F03F4581B8F1

P356

Q34498515-A69853A8-0C5B-4CC8-A068-35D01C9C7FFE

P407

Q34498515-1E9F9E59-266B-41A5-AF9D-68D13B552A28

P433

Q34498515-5433A3E9-BEE2-41D7-AA86-8719718ADE62

P478

Q34498515-970FA902-5BE9-4664-BC60-7BFB8CFAD286

P577

Q34498515-658110B7-F764-4585-B42F-21C3E27796E5

P5875

Q34498515-4E7A2BE2-54A3-4E8B-8EF1-08254B99A80D

P698

Q34498515-7B951F0C-9554-45AE-B00C-5217CFB1CFEA

P356

14656566.2015.1101448

P1433

Expert Opinion on Pharmacotherapy

P1476

Systemic lupus erythematosus: review of synthetic drugs.

@en

P2093

I E M Bultink

http://www.w3.org/2001/XMLSchema#string

M W P Tsang-A-Sjoe

http://www.w3.org/2001/XMLSchema#string

P2860

Survival in systemic lupus erythematosus, 1995-2010. A prospective study in a Danish community

Neutrophils in the pathogenesis and manifestations of SLE

mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging

The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort study

Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European Group for Blood and Marrow Transplantation registry.

Mestizos with systemic lupus erythematosus develop renal disease early while antimalarials retard its appearance: data from a Latin American cohort.

Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L)

The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide.

Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort.

Antimalarial treatment may have a time-dependent effect on lupus survival: data from a multinational Latin American inception cohort.

P304

2793-2806

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.2015.1101448

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283013383

http://www.w3.org/2001/XMLSchema#string

P698

26479437

http://www.w3.org/2001/XMLSchema#string